Clinical trial Recruiting at 1 site Interventional Ages 45 and up

Glucocorticoid injections into myofascial trigger points to treat knee osteoarthritis.

Official title: Clinical Study of Myofascial Trigger Points(MTrPs) Injection in the Treatment of Chronic Musculoskeletal Pain(CMP), Chronic Migraine and Cervicogenic Headache

Run by Beijing Tiantan Hospital · NCT07347028 · Data updated 2026-11-12

This study will test whether injecting corticosteroid into myofascial trigger points reduces pain and improves function for adults 45 and older with knee osteoarthritis.

More Migraine trials

Quick facts

Study typeInterventional
Ages45 Years and up
SexAll
Enrollment238 (estimated)
SponsorBeijing Tiantan Hospital
Academic / other
Locations1 site (Beijing, Beijing Municipality)
StatusRecruiting
StartedOctober 1, 2025
Main results expectedDecember 1, 2026
Study endsJanuary 1, 2027
Registry record updatedOctober 8, 2026
Trial IDNCT07347028 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 45 or older with radiographic knee osteoarthritis (Kellgren-Lawrence grade 1–4), disease lasting more than 3 months, an NRS pain score ≥3 despite conservative treatment, and at least one clinically confirmed myofascial trigger point who can give informed consent.

Probably not a fit

Patients with corticosteroid allergy, recent intra-articular injection, long-term steroid use, significant comorbidities (severe organ dysfunction, coagulation disorders, inflammatory rheumatic disease), substance misuse, or other exclusion criteria are unlikely to benefit from participating.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a prospective, randomized, blinded-outcome, non-inferiority trial comparing glucocorticoid injections at myofascial trigger points (MTrPs) with complex intra-articular (joint cavity) injections for knee osteoarthritis. Eligible patients are randomized to one of the two injection approaches and followed for two years. Pain (NRS), joint function (WOMAC), and other clinical outcomes are collected at prespecified intervals to compare long-term efficacy. The trial is single-center and conducted at Beijing Tiantan Hospital.

Why it matters

Potential benefit: If successful, patients could achieve similar or better long-term pain relief and function with a simpler, potentially less invasive MTrP injection approach.

How similar studies have gone: Smaller domestic and international studies have reported symptom relief from glucocorticoid injections at MTrPs, but long-term randomized comparisons versus intra-articular injections remain limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Diagnosis of knee osteoarthritis with radiographic evidence of osteoarthritis (Kellgren-Lawrence grade 1-4) confirmed by at least two orthopedic surgeons, pain specialists, or general practitioners, with physical examination confirming at least one myofascial trigger point;
* Disease duration exceeding 3 months;
* Age ≥ 45 years;
* Numerical Rating Scale (NRS) score ≥ 3 points despite prior conservative pharmacological treatment;
* Signed informed consent form.

Exclusion Criteria:

* History of allergy to trial medications such as corticosteroids;
* Alcohol abuse; long-term use of opioids (exceeding 2 weeks or more than 3 days per week for over 1 month); suspected use of sedative or analgesic medications; patients on long-term steroid therapy;
* Severe neurological disorders, significant hepatic or renal dysfunction, heart failure, coagulation abnormalities, gastric ulcer, diabetes, inflammatory rheumatic diseases, etc.;
* Intra-articular injection within the past 6 months or planned joint replacement surgery;
* Inability to use pain assessment scales;
* Presence of local or systemic infection;
* Pregnant or lactating patients.

Where it's running

  • Beijing Tiantan Hospital
    Beijing, Beijing Municipality, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.